The Food and Drug Administration has announced a recall of Drospirenone and Ethinyl Estradiol tablets that may have missing or incorrect tablet arrangement.
That's birth control, and the announcement says the patient taking these pills might not get the correct dosage if consumed according to the packaging.
"To date, no case has been reported for pregnancy and adverse event to Apotex," the recall says.
"Patients who have received impacted lots of Drospirenone and Ethinyl Estradiol Tablets, USP 3MG/0.03MG. or have questions regarding this recall please contact your pharmacy. Individuals should not interrupt their therapy, use a non-hormonal method of birth control, contact their health care provider for medical advice and may return the impacted packages to their pharmacist.
"Drospirenone and Ethinyl Estradiol Tablets, USP are an estrogen/progestin COC indicated for use by women to prevent pregnancy. Drospirenone and ethinyl estradiol tablets (inner carton) consists of 28 film-coated, biconvex tablets in the following order: 21 yellow color tablets, each containing 3 mg drospirenone (DRSP) and 0.03 mg ethinyl estradiol (EE), and 7 placebo white color tablets."
These birth control pills were distributed nationwide to wholesalers and distributors. Patients should consult their doctors. Distributors are asked to return affected products to the place of purchase.
Customers who purchased the impacted product directly from Apotex may call GENCO at 1(877) 674-2082 to arrange for their return.
Consumers with questions regarding this recall can contact Apotex corp. by phone-number (800) 706-5575or email UScustomerservice@Apotex.com .
"Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product," the recall announcement says.
